Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIARA MIA 2 after acute myocardial infarction
2016-002167-33Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Left ventricular dysfunction after myocardial infarction and myocardial infarction (MI) comparing BAY 1142524 plus standard of care with Placebo plus standard of care (2 arms). Primary endpoints: Change in left ventricular ejection fraction, Change in end-diastolic volume index and 1 more. Started Aug 2016; status: completed.
02
Drugs
fulacimstat
03
Conditions
Left ventricular dysfunction after myocardial infarctionmyocardial infarction (MI)
Beyond the preview
Go deeper on 2016-002167-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002167-33.